In the pathological process of T1DM, CTSG is involved in mediating the activation of CD4+ T cells, leading to islet inflammation and apoptosis of islet B cells, thereby affecting the function of islet B cells and leading to the progression of the disease [[37], [38], [39]]. The gene discussed is CD4; the disease is type 1 diabetes mellitus.